Is gemtuzumab/gemtuzumab (MYLOTARG) available in China?

Gemtuzumab/Gemtuzumab (MYLOTARG) is a drug used to treat acute myeloid leukemia (AML). AML is a type of leukemia caused by abnormal proliferation of white blood cells in the bone marrow. It can progress rapidly and pose a major threat to the patient's health. Gemtuzumab/Gemtuzumab is mainly used for the treatment ofAML. Specifically, it is suitable for patients who are CD33positive in their initial diagnosis of AML, as well as those who have relapsed AML or are unable to tolerate traditional treatments.

Gemtuzumab/GemtuzumabIt is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channelsGemtuzumab/Gemtuzumab. Foreign Gemtuzumab/Gemtuzumab is only Pfizer’s original drug, which is expensive, and the cheaper ones are mainly Turkish original drugs. The price of the drug is around 45,000 yuan, and the price of the original drug in Hong Kong, China is around 65,000 yuan, and the ingredients and efficacy of the original drug are consistent.

Gemtuzumab/Gemtuzumab is a monoclonal antibody drug. Its mechanism of action is to induce host immune cells to attack and eliminate these abnormally proliferated white blood cells by binding to the CD33 antigen on the surface of AML cells. This specific targeting mechanism helps reduce damage to healthy cells.

Gemtuzumab/GemtuzumabUsually used by intravenous injection, and the dosage and usage need to be determined according to the patient's specific condition and the doctor's recommendations. Treatment options may vary based on the patient's age, health, and clinical characteristics of AML.

Usinggemtuzumab/gemtuzumab may be associated with some side effects, including fever, headache, nausea, vomiting, and problems related to the immune system, such as an increased risk of infection. Patients require close monitoring while receiving treatment and supportive care as needed. Patients need to pay special attention to the guidance and supervision of their doctors when usinggemtuzumab/gemtuzumab. This medication may have different effects on certain groups of people, such as pregnant and breastfeeding women, so consult your doctor before use.